As California becomes more dependent on tax revenue from the tech industry, its stake in the health of the artificial ...

The recent upgrade of Immunovant, Inc. (IMVT) to “Outperform” by Andy Chen from Wolfe Research marks a pivotal moment for investors tracking this biopharmaceutical company. With the stock currently ...